COCP
Cocrystal Pharma, Inc. · Healthcare · Market cap $18.1M
Insiders bought $80K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Aug 6, 2026
Insider Buying
$300K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 6, 2026
FROST PHILLIP MD ET AL
Cocrystal Pharma, Inc. (COCP) has 13 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 6, 2026.
Inside the rolling window, 1 insider at Cocrystal Pharma, Inc. reported 10 open-market purchases totaling $300K and no open-market sales. The most active filer is Director, 10% Owner FROST PHILLIP MD ET AL with 10 filings. Insiders have net bought $148K over the trailing 6 months. The most recent open-market filing is a purchase of 10,000 shares by Director, 10% Owner FROST PHILLIP MD ET AL, dated Aug 5, 2026, worth $10K.
- Industry:Biotechnology
- CEO:James E. Sapirstein
- Employees:10
- HQ:Bothell, WA, US
- IPO:2012-02-22
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 10,000 | $10K | Aug 6 | -8.7% | SEC ↗ | |
FROST PHILLIP MD ET ALFirst in 5 months | Director, 10% Owner | Purchase | 75,000 | $71K | Aug 5 | -7.8% | SEC ↗ |
| Director, 10% Owner | Purchase | 20,000 | $20K | Feb 25 | -9.6% | SEC ↗ | |
| Director, 10% Owner | Purchase | 50,000 | $47K | Feb 9 | -1.1% | SEC ↗ | |
| Director, 10% Owner | Purchase | 50,000 | $47K | Jan 2 | -5.1% | SEC ↗ | |
| Director, 10% Owner | Purchase | 20,000 | $19K | Dec 31 | -4.1% | SEC ↗ | |
| Director, 10% Owner | Purchase | 25,000 | $24K | Dec 29 | -4.1% | SEC ↗ | |
| Director, 10% Owner | Purchase | 40,000 | $39K | Dec 29 | -4.1% | SEC ↗ | |
| Director, 10% Owner | Purchase | 4,000 | $4K | Nov 28 | -11.3% | SEC ↗ | |
| Director, 10% Owner | Purchase | 20,000 | $19K | Nov 25 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does COCP have?
Cocrystal Pharma, Inc. (COCP) has 13 SEC Form 4 filings (15 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 6, 2026.
When was the most recent SEC Form 4 filing for COCP?
The most recent Form 4 filing for COCP on Tracefour is dated Aug 6, 2026.
Who is the most active insider at COCP?
The most active SEC Form 4 filer at COCP in the rolling window is Director, 10% Owner FROST PHILLIP MD ET AL, with 10 filings.
What is the net insider flow at COCP over the last 6 months?
Over the trailing 180 days, insiders at COCP have net bought $148K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at COCP in the current window?
Inside the rolling window, insiders at COCP bought $300K and sold $0 based on SEC Form 4 filings.
Can I get alerts for COCP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Cocrystal Pharma, Inc. (COCP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Cocrystal Pharma, Inc. is in the Healthcare sector.